These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Nicotra B, Rivera M, Luman JI, Wallace RJ. Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981 [Abstract] [Full Text] [Related]
23. [Infections caused by Branhamella catarrhalis]. Ejlertsen T, Schønheyder H. Ugeskr Laeger; 1990 Feb 12; 152(7):475-7. PubMed ID: 2106743 [Abstract] [Full Text] [Related]
24. Branhamella catarrhalis respiratory infections. Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F. Eur Respir J; 1992 Jun 12; 5(6):675-9. PubMed ID: 1628725 [Abstract] [Full Text] [Related]
25. [Branhamella catarrhalis: its respiratory pathogenicity in childhood]. Moreno Galdo A, Ferrer Marcelles A, Aizpurúa Galdeano P, Navarro Aguirre M, Fernández Pérez F, Iglesias Berengue J. An Esp Pediatr; 1990 Aug 12; 33(2):135-9. PubMed ID: 2125809 [Abstract] [Full Text] [Related]
28. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children]. Köseoğlu O, Ergin A, Gürkan Aydin N, Hasçelik G. Mikrobiyol Bul; 2004 Oct 12; 38(4):335-40. PubMed ID: 15700658 [Abstract] [Full Text] [Related]
29. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug 12; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
31. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E, Dalhoff A, Korfmann G. Int J Antimicrob Agents; 2009 Jan 12; 33(1):52-7. PubMed ID: 18835763 [Abstract] [Full Text] [Related]
33. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Kader AA, Kumar AK. Saudi Med J; 2004 May 12; 25(5):570-4. PubMed ID: 15138522 [Abstract] [Full Text] [Related]
34. Prevalence of H.influenzae biotypes and their clinical significance in a University Hospital. Begum NN, Al-Khattaf AA, Kambal AM, Yeboah EA. Saudi Med J; 2003 Dec 12; 24(12):1308-12. PubMed ID: 14710274 [Abstract] [Full Text] [Related]
35. [Nosocomial pulmonary infections caused by Branhamella catarrhalis in intensive care units]. Denamur E, Suermondt G, Debroca A, Defouilloy C, Laurans G, Muir JF, Orfila J. Agressologie; 1989 May 12; 30(5):251-3. PubMed ID: 2508505 [Abstract] [Full Text] [Related]
36. [Branhamella catarrhalis respiratory tract infections]. Letonja S, Music E, Kumelj M. Plucne Bolesti; 1990 May 12; 42(3-4):144-7. PubMed ID: 2129309 [Abstract] [Full Text] [Related]
37. [Moraxella catarrhalis in chronic and relapsing respiratory tract infections in children]. Volkov IK, Katosova LK, Shcherbakova NIu, Kliukina LP. Antibiot Khimioter; 2004 May 12; 49(8-9):43-7. PubMed ID: 15727145 [Abstract] [Full Text] [Related]
38. Branhamella catarrhalis pneumonia in non-immunocompromised pediatric patients: report of three cases and review of the literature. Keren G, Bogokowsky B, Barzilay Z. J Med; 1989 May 12; 20(1):65-72. PubMed ID: 2496194 [Abstract] [Full Text] [Related]
39. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia. Al-Otaibi FE, Kambal AM, Baabbad RA. Saudi Med J; 2004 Jan 12; 25(1):21-5. PubMed ID: 14758373 [Abstract] [Full Text] [Related]
40. Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners. Wood GM, Johnson BC, McCormack JG. Clin Infect Dis; 1996 Apr 12; 22(4):632-6. PubMed ID: 8729201 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]